Healthcare provider profile · identity verified

Leah M Avera, MD

Family Practice · MIDDLETOWN, OH · NPI 1003892399

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	880	253
Amlodipine Besylate	Amlodipine Besylate	459	135
Losartan Potassium	Losartan Potassium	444	136
Lisinopril	Lisinopril	409	119
Levothyroxine Sodium	Levothyroxine Sodium	385	94
Rosuvastatin Calcium	Rosuvastatin Calcium	290	89
Omeprazole	Omeprazole	287	90
Gabapentin	Gabapentin	237	83
Metformin Hcl Er	Metformin Hcl	236	78
Albuterol Sulfate Hfa	Albuterol Sulfate	225	88
Metoprolol Succinate	Metoprolol Succinate	221	63
Celecoxib	Celecoxib	196	44
Pantoprazole Sodium	Pantoprazole Sodium	187	66
Famotidine	Famotidine	177	57
Sertraline Hcl	Sertraline Hcl	158	46
Ozempic	Semaglutide	139	37
Trazodone Hcl	Trazodone Hcl	136	45
Tramadol Hcl	Tramadol Hcl	128	28
Carvedilol	Carvedilol	127	38
Prednisone	Prednisone	127	100
Montelukast Sodium	Montelukast Sodium	123	39
Duloxetine Hcl	Duloxetine Hcl	120	34
Clopidogrel	Clopidogrel Bisulfate	119	28
Alendronate Sodium	Alendronate Sodium	113	35
Furosemide	Furosemide	110	38
Fluoxetine Hcl	Fluoxetine Hcl	108	33
Hydrochlorothiazide	Hydrochlorothiazide	108	36
Meloxicam	Meloxicam	108	34
Escitalopram Oxalate	Escitalopram Oxalate	103	34
Tizanidine Hcl	Tizanidine Hcl	101	34
Jardiance	Empagliflozin	95	30
Bupropion Xl	Bupropion Hcl	93	28
Metformin Hcl	Metformin Hcl	92	28
Fluticasone Propionate	Fluticasone Propionate	91	38
Glimepiride	Glimepiride	88	25
Pravastatin Sodium	Pravastatin Sodium	87	27
Simvastatin	Simvastatin	87	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	86	11
Buspirone Hcl	Buspirone Hcl	76	24
Metoprolol Tartrate	Metoprolol Tartrate	76	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	22
Pregabalin	Pregabalin	74	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	21
Citalopram Hbr	Citalopram Hydrobromide	71	23
Atenolol	Atenolol	70	21
Clonazepam	Clonazepam	67	12
Synthroid	Levothyroxine Sodium	67	22
Glipizide Er	Glipizide	65	19
Venlafaxine Hcl Er	Venlafaxine Hcl	61	17
Ezetimibe	Ezetimibe	60	18
Cephalexin	Cephalexin	57	40
Eliquis	Apixaban	56	20
Esomeprazole Magnesium	Esomeprazole Magnesium	56	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	55	46
Potassium Chloride	Potassium Chloride	55	20
Allopurinol	Allopurinol	54	15
Ondansetron Hcl	Ondansetron Hcl	53	25
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	21
Januvia	Sitagliptin Phosphate	50	11
Trulicity	Dulaglutide	50	11
Mirtazapine	Mirtazapine	48	15
Tamsulosin Hcl	Tamsulosin Hcl	48	16
Ibuprofen	Ibuprofen	47	28
Valsartan	Valsartan	46	13
Donepezil Hcl	Donepezil Hcl	45	suppressed
Fluconazole	Fluconazole	45	21
Triamcinolone Acetonide	Triamcinolone Acetonide	45	31
Hydralazine Hcl	Hydralazine Hcl	44	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	12
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Alprazolam	Alprazolam	36	suppressed
Methylprednisolone	Methylprednisolone	36	34
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	35	suppressed
Lorazepam	Lorazepam	32	suppressed
Mounjaro	Tirzepatide	31	suppressed
Meclizine Hcl	Meclizine Hcl	30	15
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Methocarbamol	Methocarbamol	29	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	28	suppressed
Topiramate	Topiramate	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Lansoprazole	Lansoprazole	27	suppressed
Naproxen	Naproxen	26	11
Rizatriptan	Rizatriptan Benzoate	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	18
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Repatha Sureclick	Evolocumab	25	suppressed
Spironolactone	Spironolactone	25	11
Azithromycin	Azithromycin	24	23
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	18
Terazosin Hcl	Terazosin Hcl	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	13
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	18
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Nystatin	Nystatin	19	16
Primidone	Primidone	19	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Colchicine	Colchicine	17	suppressed
Klor-Con M10	Potassium Chloride	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	14
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Clonidine Hcl	Clonidine Hcl	15	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Mupirocin	Mupirocin	13	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Nitroglycerin Patch	Nitroglycerin	12	suppressed
Prolia	Denosumab	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Glipizide	Glipizide	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error